Thomson Medical Group (TMG) said that it is adding three new members to its Board in a move that will make it highly diverse by gender, age and experience. The three directors are Christina Teo Tze Wei and June Leong Lai Ling, both of whom will be Non-executive and Independent Directors, and Wan Nadiah who will be an Executive Director. At the same time, TMG has appointed Lim Wee Kiat as CEO of Thomson X (TX), and redesignated him from Non-Executive to Executive Director of TMG. All appointments and redesignation will take effect from 1 January 2022. The new appointments will expand the Board's membership from seven to nine, and follow the retirement of Director Freddie Heng at the Company's annual general meeting on 22 October 2021.